retatrutide clinical trials review vs Ozempic: Trial Comparisons Retatrutide, an experimental drug currently

Glucagon Receptor Engagement : The addition of glucagon receptor activation is the core feature that separates Retatrutide from dual-agonist compounds

Thus, BED appears to involve GLP-1 dysregulation without consistent endocrine abnormalities, implying that GLP-1 RA therapy works through supraphysiological receptor activation and modulation of central reward circuitry, rather than by correcting a hormonal deficit [55]

However, people using compounded semaglutide may not see the weight loss they expect, for various reasons

Severe allergic events remain rare across all three medications

J Endocrinol (2021) 248(3):289301

GLP-1 medications such as semaglutide and tirzepatide are injected under the skin (subcutaneous), not into muscle